Research-use status: Cagrilintide is sold by research peptide suppliers as a lyophilized powder for in-vitro and laboratory research only
There is one open-label intravenous safety pilot in two healthy adults, who received single doses of 10 mg and 20 mg with no comparator, no blinding, and short-term observation limited to vital signs, self reported symptoms and labs across two days [4]
Who Should Consider Exosome Therapy Exosome therapy is ideal for individuals seeking a non-surgical, minimally invasive solution to aging, chronic inflammation, and fatigue
Researchers should use sterile equipment, avoid unnecessary vial punctures, and regularly inspect laboratory materials before each use
For more information, contact us today or schedule an appointment
Common candidates include: Individuals experiencing dehydration: Those who are dehydrated due to illness, excessive heat, strenuous exercise, or vomiting may benefit from IV rehydration